October 5, 2020 – HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
July 30, 2020 – HSCA Letter to the House Committee on Energy and Commerce
July 29, 2020 – HSCA Comments to the Senate HELP Committee on Planning for the Next Pandemic
May 14, 2020 – Comments of the Healthcare Supply Chain Association on USTR Request for Comments on Additional Tariff Exclusions for COVID-19 Response
April 10, 2020 – Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on Ensuring a Competitive Marketplace for Biosimilars
March 24, 2020 – HSCA Releases Third Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
March 11, 2020 – HSCA Applauds House Committee on Energy and Commerce for Commitment to Supporting Quality and Protecting Patients from Counterfeit Medical Products
March 11, 2020 – HSCA Statement on House Committee on Homeland Security Hearing on the Coronavirus
March 10, 2020 – Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on the Importation of Prescription Drugs
March 3, 2020 – HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
February 28, 2020 – Joint Letter of Support for Swift Action on the MEDS Act
January 28, 2020 – Group Comment Letter to FDA on Clinical Immunogenicity Considerations from Biosimilar and Interchangeable Insulin Products